1 | identify | 21,062 |
2 | classify | 522 |
3 | discover | 420 |
4 | locate | 315 |
5 | stratify | 263 |
6 | retrieve | 244 |
7 | uncover | 221 |
8 | categorize | 183 |
9 | risk-stratify | 32 |
10 | categorise | 24 |
11 | indentify | 13 |
12 | anticoagulate | 10 |
13 | dichotomize | 8 |
14 | codify | 7 |
15 | preselect | 7 |
16 | orientate | 6 |
17 | re-analyse | 6 |
18 | immunise | 4 |
19 | obturate | 4 |
20 | invent | 3 |
21 | pre-select | 3 |
22 | anaesthetize | 2 |
23 | avoid/minimize | 2 |
24 | clinicians-and | 2 |
25 | ct-treated | 2 |
26 | high-predicted | 2 |
27 | injuring/injured | 2 |
28 | overpower | 2 |
29 | parcellate | 2 |
30 | problematize | 2 |
31 | reengage | 2 |
32 | 1-5775 | 1 |
33 | 103,613 | 1 |
34 | 11507 | 1 |
35 | 13,568 | 1 |
36 | 133,449 | 1 |
37 | 14,213 | 1 |
38 | 14/150 | 1 |
39 | 18,554 | 1 |
40 | 19.0/100 | 1 |
41 | 2-high | 1 |
42 | 230.505 | 1 |
43 | 26,552 | 1 |
44 | 26.1±8.7mg | 1 |
45 | 26/191 | 1 |
46 | 28.10/100,000 | 1 |
47 | 29.00/100,000 | 1 |
48 | 3-fold-increased | 1 |
49 | 34,050 | 1 |
50 | 43/100 | 1 |
51 | 43/78 | 1 |
52 | 445,900 | 1 |
53 | 5-low | 1 |
54 | 51,459 | 1 |
55 | 54,254 | 1 |
56 | 541/1052 | 1 |
57 | 596/1000 | 1 |
58 | 6-5882 | 1 |
59 | 61/97 | 1 |
60 | 64,469 | 1 |
61 | 71,984 | 1 |
62 | 7351 | 1 |
63 | 7552 | 1 |
64 | 7617 | 1 |
65 | 8,078 | 1 |
66 | 80/1000 | 1 |
67 | 8083 | 1 |
68 | 9,560.-ecu | 1 |
69 | acculturation-related | 1 |
70 | all-including | 1 |
71 | analize | 1 |
72 | anatomical-hereditary | 1 |
73 | biopsiable | 1 |
74 | cell-and-terminal | 1 |
75 | cgggg | 1 |
76 | control.fourteen | 1 |
77 | controlfor | 1 |
78 | core-region | 1 |
79 | ctnt-based | 1 |
80 | cvd-specific | 1 |
81 | d4t-exposed | 1 |
82 | debias | 1 |
83 | dengue-immune | 1 |
84 | dentin-analog | 1 |
85 | desalt | 1 |
86 | determine- | 1 |
87 | dietbased | 1 |
88 | disease/injury-affected | 1 |
89 | dmt-treatment-naïve | 1 |
90 | e-refer | 1 |
91 | ecv.although | 1 |
92 | extra-osseus | 1 |
93 | family-mediating | 1 |
94 | fft-high | 1 |
95 | find-out | 1 |
96 | gbr-treated | 1 |
97 | genetic-biological | 1 |
98 | good.nine | 1 |
99 | grass-treated | 1 |
100 | harm=25 | 1 |
101 | high-ts | 1 |
102 | hra-o-identified | 1 |
103 | hydrochlorothiazide-triamterene | 1 |
104 | hyper-cholesterol | 1 |
105 | ideniify | 1 |
106 | identify/formulate | 1 |
107 | identify/rank | 1 |
108 | immunocompentent | 1 |
109 | imrt-e. | 1 |
110 | incorparate | 1 |
111 | infectious/autoimmune | 1 |
112 | jastreboff | 1 |
113 | lftu | 1 |
114 | lifestyle-dependent | 1 |
115 | lymphodepleted | 1 |
116 | lysolipid-containing | 1 |
117 | meta-analyse.three | 1 |
118 | mldl-ic | 1 |
119 | non-ascitic | 1 |
120 | non-combusted | 1 |
121 | non-correlated | 1 |
122 | non-mrd | 1 |
123 | non-overhydrated | 1 |
124 | non-ph-like | 1 |
125 | non-poisoned | 1 |
126 | non-rewarded | 1 |
127 | non-septicemia | 1 |
128 | non-spinal/vertebral | 1 |
129 | nondevice | 1 |
130 | nonestimable | 1 |
131 | nonlimbic | 1 |
132 | normozincemic | 1 |
133 | parasite-endemic | 1 |
134 | parent-of-origin | 1 |
135 | participate.38 | 1 |
136 | patient-inherent | 1 |
137 | perform/understand | 1 |
138 | phobic-resistant | 1 |
139 | pirate | 1 |
140 | placebo/delayed | 1 |
141 | plrygbp | 1 |
142 | pre-perampanel | 1 |
143 | pseudomonas-positive | 1 |
144 | rct-related | 1 |
145 | rcts/clinical | 1 |
146 | reductionism-based | 1 |
147 | retain/eliminate | 1 |
148 | sixty-five-year-old | 1 |
149 | skin-warming | 1 |
150 | ssz-treated | 1 |
151 | stat-binding | 1 |
152 | subhumid | 1 |
153 | surgically-fit | 1 |
154 | surveillance-only | 1 |
155 | tamoxifen-taking | 1 |
156 | theophylline-responsive | 1 |
157 | track/graph | 1 |
158 | treatment-12 | 1 |
159 | unpropitious | 1 |
160 | unscramble | 1 |
161 | whisk | 1 |
162 | work.four | 1 |
163 | £6005 | 1 |
164 | β3t-negative | 1 |
1 | 1-5775 | 1 |
2 | 103,613 | 1 |
3 | 11507 | 1 |
4 | 13,568 | 1 |
5 | 133,449 | 1 |
6 | 14,213 | 1 |
7 | 14/150 | 1 |
8 | 18,554 | 1 |
9 | 19.0/100 | 1 |
10 | 2-high | 1 |
11 | 230.505 | 1 |
12 | 26,552 | 1 |
13 | 26.1±8.7mg | 1 |
14 | 26/191 | 1 |
15 | 28.10/100,000 | 1 |
16 | 29.00/100,000 | 1 |
17 | 3-fold-increased | 1 |
18 | 34,050 | 1 |
19 | 43/100 | 1 |
20 | 43/78 | 1 |
21 | 445,900 | 1 |
22 | 5-low | 1 |
23 | 51,459 | 1 |
24 | 54,254 | 1 |
25 | 541/1052 | 1 |
26 | 596/1000 | 1 |
27 | 6-5882 | 1 |
28 | 61/97 | 1 |
29 | 64,469 | 1 |
30 | 71,984 | 1 |
31 | 7351 | 1 |
32 | 7552 | 1 |
33 | 7617 | 1 |
34 | 8,078 | 1 |
35 | 80/1000 | 1 |
36 | 8083 | 1 |
37 | 9,560.-ecu | 1 |
38 | acculturation-related | 1 |
39 | all-including | 1 |
40 | anaesthetize | 2 |
41 | analize | 1 |
42 | anatomical-hereditary | 1 |
43 | anticoagulate | 10 |
44 | avoid/minimize | 2 |
45 | biopsiable | 1 |
46 | categorise | 24 |
47 | categorize | 183 |
48 | cell-and-terminal | 1 |
49 | cgggg | 1 |
50 | classify | 522 |
51 | clinicians-and | 2 |
52 | codify | 7 |
53 | control.fourteen | 1 |
54 | controlfor | 1 |
55 | core-region | 1 |
56 | ct-treated | 2 |
57 | ctnt-based | 1 |
58 | cvd-specific | 1 |
59 | d4t-exposed | 1 |
60 | debias | 1 |
61 | dengue-immune | 1 |
62 | dentin-analog | 1 |
63 | desalt | 1 |
64 | determine- | 1 |
65 | dichotomize | 8 |
66 | dietbased | 1 |
67 | discover | 420 |
68 | disease/injury-affected | 1 |
69 | dmt-treatment-naïve | 1 |
70 | e-refer | 1 |
71 | ecv.although | 1 |
72 | extra-osseus | 1 |
73 | family-mediating | 1 |
74 | fft-high | 1 |
75 | find-out | 1 |
76 | gbr-treated | 1 |
77 | genetic-biological | 1 |
78 | good.nine | 1 |
79 | grass-treated | 1 |
80 | harm=25 | 1 |
81 | high-predicted | 2 |
82 | high-ts | 1 |
83 | hra-o-identified | 1 |
84 | hydrochlorothiazide-triamterene | 1 |
85 | hyper-cholesterol | 1 |
86 | ideniify | 1 |
87 | identify | 21,062 |
88 | identify/formulate | 1 |
89 | identify/rank | 1 |
90 | immunise | 4 |
91 | immunocompentent | 1 |
92 | imrt-e. | 1 |
93 | incorparate | 1 |
94 | indentify | 13 |
95 | infectious/autoimmune | 1 |
96 | injuring/injured | 2 |
97 | invent | 3 |
98 | jastreboff | 1 |
99 | lftu | 1 |
100 | lifestyle-dependent | 1 |
101 | locate | 315 |
102 | lymphodepleted | 1 |
103 | lysolipid-containing | 1 |
104 | meta-analyse.three | 1 |
105 | mldl-ic | 1 |
106 | non-ascitic | 1 |
107 | non-combusted | 1 |
108 | non-correlated | 1 |
109 | non-mrd | 1 |
110 | non-overhydrated | 1 |
111 | non-ph-like | 1 |
112 | non-poisoned | 1 |
113 | non-rewarded | 1 |
114 | non-septicemia | 1 |
115 | non-spinal/vertebral | 1 |
116 | nondevice | 1 |
117 | nonestimable | 1 |
118 | nonlimbic | 1 |
119 | normozincemic | 1 |
120 | obturate | 4 |
121 | orientate | 6 |
122 | overpower | 2 |
123 | parasite-endemic | 1 |
124 | parcellate | 2 |
125 | parent-of-origin | 1 |
126 | participate.38 | 1 |
127 | patient-inherent | 1 |
128 | perform/understand | 1 |
129 | phobic-resistant | 1 |
130 | pirate | 1 |
131 | placebo/delayed | 1 |
132 | plrygbp | 1 |
133 | pre-perampanel | 1 |
134 | pre-select | 3 |
135 | preselect | 7 |
136 | problematize | 2 |
137 | pseudomonas-positive | 1 |
138 | rct-related | 1 |
139 | rcts/clinical | 1 |
140 | re-analyse | 6 |
141 | reductionism-based | 1 |
142 | reengage | 2 |
143 | retain/eliminate | 1 |
144 | retrieve | 244 |
145 | risk-stratify | 32 |
146 | sixty-five-year-old | 1 |
147 | skin-warming | 1 |
148 | ssz-treated | 1 |
149 | stat-binding | 1 |
150 | stratify | 263 |
151 | subhumid | 1 |
152 | surgically-fit | 1 |
153 | surveillance-only | 1 |
154 | tamoxifen-taking | 1 |
155 | theophylline-responsive | 1 |
156 | track/graph | 1 |
157 | treatment-12 | 1 |
158 | uncover | 221 |
159 | unpropitious | 1 |
160 | unscramble | 1 |
161 | whisk | 1 |
162 | work.four | 1 |
163 | £6005 | 1 |
164 | β3t-negative | 1 |
1 | determine- | 1 |
2 | imrt-e. | 1 |
3 | 29.00/100,000 | 1 |
4 | 28.10/100,000 | 1 |
5 | 80/1000 | 1 |
6 | 596/1000 | 1 |
7 | 19.0/100 | 1 |
8 | 43/100 | 1 |
9 | 445,900 | 1 |
10 | 34,050 | 1 |
11 | 14/150 | 1 |
12 | 7351 | 1 |
13 | 26/191 | 1 |
14 | treatment-12 | 1 |
15 | 541/1052 | 1 |
16 | 26,552 | 1 |
17 | 7552 | 1 |
18 | 6-5882 | 1 |
19 | 14,213 | 1 |
20 | 103,613 | 1 |
21 | 8083 | 1 |
22 | 54,254 | 1 |
23 | 18,554 | 1 |
24 | 71,984 | 1 |
25 | £6005 | 1 |
26 | 230.505 | 1 |
27 | harm=25 | 1 |
28 | 1-5775 | 1 |
29 | 11507 | 1 |
30 | 7617 | 1 |
31 | 61/97 | 1 |
32 | participate.38 | 1 |
33 | 13,568 | 1 |
34 | 43/78 | 1 |
35 | 8,078 | 1 |
36 | 133,449 | 1 |
37 | 51,459 | 1 |
38 | 64,469 | 1 |
39 | non-septicemia | 1 |
40 | mldl-ic | 1 |
41 | nonlimbic | 1 |
42 | cvd-specific | 1 |
43 | normozincemic | 1 |
44 | parasite-endemic | 1 |
45 | non-ascitic | 1 |
46 | non-rewarded | 1 |
47 | hra-o-identified | 1 |
48 | non-poisoned | 1 |
49 | injuring/injured | 2 |
50 | reductionism-based | 1 |
51 | ctnt-based | 1 |
52 | dietbased | 1 |
53 | 3-fold-increased | 1 |
54 | d4t-exposed | 1 |
55 | gbr-treated | 1 |
56 | grass-treated | 1 |
57 | ct-treated | 2 |
58 | ssz-treated | 1 |
59 | acculturation-related | 1 |
60 | rct-related | 1 |
61 | non-correlated | 1 |
62 | non-overhydrated | 1 |
63 | disease/injury-affected | 1 |
64 | high-predicted | 2 |
65 | lymphodepleted | 1 |
66 | non-combusted | 1 |
67 | placebo/delayed | 1 |
68 | subhumid | 1 |
69 | sixty-five-year-old | 1 |
70 | clinicians-and | 2 |
71 | perform/understand | 1 |
72 | non-mrd | 1 |
73 | nondevice | 1 |
74 | meta-analyse.three | 1 |
75 | reengage | 2 |
76 | non-ph-like | 1 |
77 | biopsiable | 1 |
78 | nonestimable | 1 |
79 | unscramble | 1 |
80 | hydrochlorothiazide-triamterene | 1 |
81 | good.nine | 1 |
82 | dengue-immune | 1 |
83 | infectious/autoimmune | 1 |
84 | immunise | 4 |
85 | categorise | 24 |
86 | re-analyse | 6 |
87 | locate | 315 |
88 | parcellate | 2 |
89 | anticoagulate | 10 |
90 | identify/formulate | 1 |
91 | retain/eliminate | 1 |
92 | incorparate | 1 |
93 | pirate | 1 |
94 | obturate | 4 |
95 | orientate | 6 |
96 | retrieve | 244 |
97 | theophylline-responsive | 1 |
98 | β3t-negative | 1 |
99 | pseudomonas-positive | 1 |
100 | dmt-treatment-naïve | 1 |
101 | analize | 1 |
102 | avoid/minimize | 2 |
103 | dichotomize | 8 |
104 | categorize | 183 |
105 | problematize | 2 |
106 | anaesthetize | 2 |
107 | jastreboff | 1 |
108 | cgggg | 1 |
109 | 26.1±8.7mg | 1 |
110 | stat-binding | 1 |
111 | all-including | 1 |
112 | tamoxifen-taking | 1 |
113 | skin-warming | 1 |
114 | lysolipid-containing | 1 |
115 | family-mediating | 1 |
116 | dentin-analog | 1 |
117 | 2-high | 1 |
118 | fft-high | 1 |
119 | ecv.although | 1 |
120 | track/graph | 1 |
121 | identify/rank | 1 |
122 | whisk | 1 |
123 | genetic-biological | 1 |
124 | rcts/clinical | 1 |
125 | cell-and-terminal | 1 |
126 | non-spinal/vertebral | 1 |
127 | pre-perampanel | 1 |
128 | hyper-cholesterol | 1 |
129 | control.fourteen | 1 |
130 | parent-of-origin | 1 |
131 | core-region | 1 |
132 | plrygbp | 1 |
133 | e-refer | 1 |
134 | uncover | 221 |
135 | discover | 420 |
136 | overpower | 2 |
137 | controlfor | 1 |
138 | work.four | 1 |
139 | debias | 1 |
140 | high-ts | 1 |
141 | extra-osseus | 1 |
142 | unpropitious | 1 |
143 | pre-select | 3 |
144 | preselect | 7 |
145 | surgically-fit | 1 |
146 | desalt | 1 |
147 | phobic-resistant | 1 |
148 | lifestyle-dependent | 1 |
149 | patient-inherent | 1 |
150 | immunocompentent | 1 |
151 | invent | 3 |
152 | find-out | 1 |
153 | 9,560.-ecu | 1 |
154 | lftu | 1 |
155 | 5-low | 1 |
156 | codify | 7 |
157 | ideniify | 1 |
158 | classify | 522 |
159 | stratify | 263 |
160 | risk-stratify | 32 |
161 | identify | 21,062 |
162 | indentify | 13 |
163 | surveillance-only | 1 |
164 | anatomical-hereditary | 1 |